Wojcicki and New Mountain have offered to acquire all of 23andMe's outstanding shares in cash for $2.53 per share, or an equity value of approximately $74.7 million. The company's stock closed at ...

23andMe's special committee of independent directors ... according to a filing with the U.S. Securities and Exchange ...

The latest plan by 23andMe co-founder and CEO Anne Wojcicki to acquire the genetic testing company was rejected by a special ...

The Special Committee has reviewed Ms. Wojcicki’s acquisition proposal in consultation with its financial and legal advisors, and has unanimously determined to reject the proposal. Moelis & Company ...

Experts say the CEO’s second attempt to buy back the troubled DNA startup comes with a slew of corporate governance red flags ...

The Securities and Exchange Commission issued guidance Thursday evening saying it does not deem most meme coins securities ...

23andMe's special committee of independent ... according to a filing with the U.S. Securities and Exchange Commission. The stock plunged 33% on Monday to close at $1.47, down more than 99% from ...

according to a Friday filing with the U.S. Securities and Exchange Commission. Wojcicki and New Mountain have offered to acquire all of 23andMe's outstanding shares in cash for $2.53 per share ...

The special committee of the board of directors of 23andMe (ME) confirmed receipt of a non-binding proposal from Anne Wojcicki, CEO, ...